2-Bromo-3-(trifluoromethyl)benzoic acid, 95.0%, 250mg

2-(o-Tolyl)ethanol, 95.0%, 10g

4-methyl-N-(6-sulfanylpyridazin-3-yl)benzamide, 95.0%, 250mg

2,2-DIFLUORO-2-MESITYLACETIC ACID, 95%, 100mg

2-Ethoxy-6-fluorobenzylamine, 98.0%, 1g

Quaderni da laboratorio, neri, pagine numerate, senza acidi, a quadretti 12 pz

fmoc-d-n-me-val-oh, 95.0%, 25g

3-(3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride, 95.0%, 250mg

1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl Trifluoromethanesulfonate>98.0%(HPLC)(T)5g

1-[(2E)-3-phenylprop-2-en-1-yl]-1,4-diazepane, 95.0%, 1g

Methyl 7-(2-methoxyethyl)-1,3-dimethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyrimidine-6-carboxylate, 97%, 100mg

6-Methoxy-2-methyl-2,3-dihydro-1H-inden-1-one, 98%, 250mg

Methyl 6-bromo-2H-chromene-3-carboxylate, 96%, 100mg